axSpA/AS
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The participants selected for this study must meet all of the following inclusion criteria: 1) Age between 18 and 75 years old; 2) Gender is not restricted; 3) Meet the classification criteria for axial spondyloarthritis (SpA) recommended by the International Ankylosing Spondylitis Assessment Group in 2009. 4) Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP): 1.3 - 3.5; 5) No use of non-steroidal anti-inflammatory drugs within 2 weeks before enrollment; if using non-steroidal anti-inflammatory drugs, they must have been using them stably for 1 month before enrollment. 6) No use of biologics within 3 months before enrollment. If using biologics, they need to have been using them stably for 1 month before enrollment to be included; 7) No participation in any traditional Chinese medicine non-pharmacological trials within 4 weeks before enrollment; 8) Able to practice Yi Jin Jing for 3 months; 9) Voluntary to participate in the study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: The participants will not be eligible to participate in this trial if they have any of the following conditions: 1) Pregnant women, women preparing for pregnancy or those in lactation period; 2) Those who have had or currently have malignant tumors; 3) Those with acute or chronic infectious diseases; 4) Those diagnosed with other rheumatic immune diseases; 5) Patients with other known diseases that require special attention in the exercise rehabilitation program, such as patients with cardiovascular diseases or those with a high-risk assessment of cardiovascular conditions; patients with cervical vertebral bone bridges; patients who have undergone surgical treatment within the past 6 months; 6) Patients who have been regularly exercising (such as yoga, Tai Chi, Ba Duan Jin, etc., = 3 times/week, 20 minutes each time) in the past 3 months; patients who have used self-management applications for chronic diseases or received corresponding treatment before; 7)Those considered by the researchers not to meet the requirements for joining this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ankylosing Spondylitis Disease Activity Score with C-reactive protein ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Ankylosing Spondylitis Disease Activity Score with C-reactive protein;Assessment in Spondylarthritis International Society for 20 % improvement;Bath Ankylosing Spondylitis Disease Activity Index;Bath Ankylosing Spondylitis Functional Index;Bath Ankylosing Spondylitis Metrology Index;Medical Outcomes Study 36-Item Short-Form Health Survey;Complete blood count;erythrocyte sedimentation Rate;C-reactive protein; | — |
Countries
China
Contacts
Beijing University of Chinese Medicine Dongzhimen Hospital